
Estradiol Valerate
Estradiol Valerate API (CAS No: 979-32-8) is manufactured by Amber Lifesciences Pvt. Ltd. in advanced GMP and ISO 9001:2015 certified facilities, ensuring high purity, safety, and stability for regulated pharmaceutical use. Fully compliant with BP and USP pharmacopeial standards, this Active Pharmaceutical Ingredient is supplied with a Certificate of Analysis (CoA) and Material Safety Data Sheet (MSDS) to support global regulatory submissions.
Primarily used in injectable formulations, Estradiol Valerate is indicated for hormone replacement therapy (HRT), menopausal symptom management, and treatment of estrogen-related gynecological conditions. Each batch undergoes rigorous quality testing to ensure consistency and meet the requirements of regulated markets.
Amber Lifesciences serves pharmaceutical companies, manufacturers, traders, and distributors across LATAM, Asia, Europe, and other regions, offering dependable supply, technical support, and transparent processes for both evaluation and commercial production.
Storage & Transportation:
Classified as non-dangerous goods. Store at 20°C to 25°C (68°F to 77°F), protected from light and moisture. Follow standard handling procedures to preserve quality.
CAT No.: | EST-VAL-18 |
|---|---|
CAS No.: | 979-32-8 |
Synonym: | Estra-1,3,5(10)-triene-3,17β-diol 17-pentanoate |
Mol. formula: | C₂₃H₃₂O₃ |
Mol. Weight: | 356.5 g/mol |
Active Pharmaceutical Ingredient (API) – Not for Direct Human or Veterinary Use.